From: Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma
Variable | Subset | Overall survival | ||
---|---|---|---|---|
 |  | HR | 95% CI | P |
miR-25 expression | High/low | 2.179 | 1.876-4.335 | 0.001 |
Gender | Male/female | 0.982 | 0.901-1.003 | 0.652 |
Age at diagnosis | >50/≤50 | 1.231 | 0.922-1.523 | 0.212 |
Tumor size | >5/≤5 | 1.479 | 0.991-2.127 | 0.090 |
Tumor number | Multiple/solitary | 1.854 | 0.823-2.132 | 0.121 |
TNM stage | III-IV/I-II | 1.782 | 1.389-2.993 | 0.014 |
Vein invasion | Presence/absence | 1.624 | 1.233-1.981 | 0.020 |
Cirrhosis | Positive/negative | 1.027 | 0.876-1.535 | 0.320 |
Hepatitis B virus infection | Positive/negative | 1.002 | 0.892-1.337 | 0.417 |
Serum AFP level | >25/≤25 | 1.377 | 0.882-1.335 | 0.398 |